Karnieli O - Search Results

1

Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies.

Kim JH, Kawase E, Bharti K, Karnieli O, Arakawa Y, Stacey G. Kim JH, et al. Among authors: karnieli o. NPJ Regen Med. 2022 Sep 29;7(1):54. doi: 10.1038/s41536-022-00242-7. NPJ Regen Med. 2022. PMID: 36175440 Free PMC article.

2

Concise review: guidance in developing commercializable autologous/patient-specific cell therapy manufacturing.

Eaker S, Armant M, Brandwein H, Burger S, Campbell A, Carpenito C, Clarke D, Fong T, Karnieli O, Niss K, Van't Hof W, Wagey R. Eaker S, et al. Among authors: karnieli o. Stem Cells Transl Med. 2013 Nov;2(11):871-83. doi: 10.5966/sctm.2013-0050. Epub 2013 Oct 7. Stem Cells Transl Med. 2013. PMID: 24101671 Free PMC article. Review.

3

Concise Review: Process Development Considerations for Cell Therapy.

Campbell A, Brieva T, Raviv L, Rowley J, Niss K, Brandwein H, Oh S, Karnieli O. Campbell A, et al. Among authors: karnieli o. Stem Cells Transl Med. 2015 Oct;4(10):1155-63. doi: 10.5966/sctm.2014-0294. Epub 2015 Aug 27. Stem Cells Transl Med. 2015. PMID: 26315572 Free PMC article. Review.

4

Managing particulates in cell therapy: Guidance for best practice.

Clarke D, Stanton J, Powers D, Karnieli O, Nahum S, Abraham E, Parisse JS, Oh S. Clarke D, et al. Among authors: karnieli o. Cytotherapy. 2016 Sep;18(9):1063-76. doi: 10.1016/j.jcyt.2016.05.011. Epub 2016 Jul 12. Cytotherapy. 2016. PMID: 27426934 Review.

5

Managing particulates in cellular therapy.

Clarke D, Harati D, Martin J, Rowley J, Keller J, McCaman M, Carrion M, Karnieli O, Maziarz R, Perry R, Oh S, Stanton J. Clarke D, et al. Among authors: karnieli o. Cytotherapy. 2012 Oct;14(9):1032-40. doi: 10.3109/14653249.2012.706709. Epub 2012 Aug 17. Cytotherapy. 2012. PMID: 22900960 Review.

6

A consensus introduction to serum replacements and serum-free media for cellular therapies.

Karnieli O, Friedner OM, Allickson JG, Zhang N, Jung S, Fiorentini D, Abraham E, Eaker SS, Yong TK, Chan A, Griffiths S, Wehn AK, Oh S, Karnieli O. Karnieli O, et al. Cytotherapy. 2017 Feb;19(2):155-169. doi: 10.1016/j.jcyt.2016.11.011. Epub 2016 Dec 22. Cytotherapy. 2017. PMID: 28017599 Review.

7

Corrigendum to "A consensus introduction to serum replacements and serum-free media for cellular therapies" [Cytotherapy 19 (2017) 155-169].

Karnieli O, Friedner OM, Allickson JG, Zhang N, Jung S, Fiorentini D, Abraham E, Eaker SS, Yong TK, Chan A, Griffiths S, Wehn AK, Oh S, Karnieli O. Karnieli O, et al. Cytotherapy. 2018 Feb;20(2):271. doi: 10.1016/j.jcyt.2017.11.007. Epub 2017 Dec 6. Cytotherapy. 2018. PMID: 29223535 No abstract available.

8

Critical elements in the development of cell therapy potency assays for ischemic conditions.

Porat Y, Abraham E, Karnieli O, Nahum S, Woda J, Zylberberg C. Porat Y, et al. Among authors: karnieli o. Cytotherapy. 2015 Jul;17(7):817-31. doi: 10.1016/j.jcyt.2014.08.014. Epub 2015 Feb 26. Cytotherapy. 2015. PMID: 25728414 Review.

9

In-Hospital Manufacturing of Cellular Therapies Using Automated Systems.

Kadauke S, Bonamino MH, Levine BL, Harrison R, Karnieli O. Kadauke S, et al. Among authors: karnieli o. Clin Chem. 2023 Sep 1;69(9):954-960. doi: 10.1093/clinchem/hvad102. Clin Chem. 2023. PMID: 37478367 No abstract available.

10

Canine procalcitonin messenger RNA expression.

Kuzi S, Aroch I, Peleg K, Karnieli O, Klement E, Dank G. Kuzi S, et al. Among authors: karnieli o. J Vet Diagn Invest. 2008 Sep;20(5):629-33. doi: 10.1177/104063870802000516. J Vet Diagn Invest. 2008. PMID: 18776098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters